123 related articles for article (PubMed ID: 6200631)
1. [Heterogeneity of alpha-fetoprotein with concanavalin A-binding properties in the serum and ascites of liver neoplasms and liver cirrhosis].
Fujise K; Nagamori S; Hasumura S; Homma S; Sujino H; Kameda H
Nihon Shokakibyo Gakkai Zasshi; 1983 Nov; 80(11):2363-8. PubMed ID: 6200631
[No Abstract] [Full Text] [Related]
2. Extreme elevation of serum alpha fetoprotein in decompensated cirrhosis without HCC: an ominous sign.
Senturk H; Cumali R
Int J Biol Markers; 2007; 22(1):19-23. PubMed ID: 17393357
[TBL] [Abstract][Full Text] [Related]
3. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
4. [Immunochemical determination of alpha-fetoprotein in the dynamics of development of liver cirrhosis and hepatocellular cancer].
Afanas'eva KA; Ragozin IuE; Tatarinov IuS
Vestn Akad Med Nauk SSSR; 1975; (6):71-3. PubMed ID: 58499
[No Abstract] [Full Text] [Related]
5. [Alpha-fetoprotein in relation to the age of the subject. Normal and pathological levels].
Hurjui J; Teodorovici I; Creţeanu M
Rev Med Chir Soc Med Nat Iasi; 1980; 84(2):283-6. PubMed ID: 6164085
[No Abstract] [Full Text] [Related]
6. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis].
Denis I; Beaudonnet A; Pichot J; Roubille M; Gelineau M
Ann Biol Clin (Paris); 2000; 58(1):85-90. PubMed ID: 10673618
[No Abstract] [Full Text] [Related]
7. Alpha1-fetoprotein in liver disease in Sarawak.
Kothare SN
Singapore Med J; 1978 Dec; 19(4):220-4. PubMed ID: 87015
[No Abstract] [Full Text] [Related]
8. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
Niermeijer P; Gips CH; Marrink J; QUE GS
Neth J Med; 1976; 19(1):25-8. PubMed ID: 55985
[No Abstract] [Full Text] [Related]
9. Early detection of hepatoma in cirrhosis by serial quantitation of alpha-1-foetoprotein in serum.
Niermeijer P; Gips CH; Marrink J; Qué GS
Neth J Med; 1976; 19(1):15-8. PubMed ID: 55984
[No Abstract] [Full Text] [Related]
10. [Alpha-fetoprotein as a tumor marker].
Yachi A; Suga M
Nihon Rinsho; 1980 Dec; 38(12):4554-9. PubMed ID: 6166768
[No Abstract] [Full Text] [Related]
11. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.
Sato Y; Nakata K; Kato Y; Shima M; Ishii N; Koji T; Taketa K; Endo Y; Nagataki S
N Engl J Med; 1993 Jun; 328(25):1802-6. PubMed ID: 7684823
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study on the patterns of sequential fluctuation of serum alpha-fetoprotein level during progression from liver cirrhosis to hepatocellular carcinoma.
Imaeda T; Doi H
J Gastroenterol Hepatol; 1992; 7(2):132-5. PubMed ID: 1373964
[TBL] [Abstract][Full Text] [Related]
13. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis.
Arrieta O; Cacho B; Morales-Espinosa D; Ruelas-Villavicencio A; Flores-Estrada D; Hernández-Pedro N
BMC Cancer; 2007 Feb; 7():28. PubMed ID: 17288606
[TBL] [Abstract][Full Text] [Related]
14. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Fabris C; Basso DA; Leandro G; Meggiato T; Elba S; Panozzo MP; Del Favero G; Fogar P; Di Mario F; Naccarato R
Cancer; 1991 Oct; 68(8):1795-8. PubMed ID: 1717126
[TBL] [Abstract][Full Text] [Related]
15. Serum CA 19-9 and alpha-fetoprotein levels in primary hepatocellular carcinoma and liver cirrhosis.
Collazos J
Cancer; 1992 Sep; 70(5):1202-3. PubMed ID: 1381271
[No Abstract] [Full Text] [Related]
16. alpha-Fetoprotein screening in patients with idiopathic hemochromatosis and liver cirrhosis.
Chayvialle JA; Brissot P; Pelletier MJ; Hita de Nercy Y; Lambert R; Bourel M
Digestion; 1977; 16(1-2):118-27. PubMed ID: 79512
[TBL] [Abstract][Full Text] [Related]
17. [Serum concentrations of alpha-1-fetoprotein suggestive of, or pathognomonic for hepatoma (author's transl)].
Polterauer P; Horak W; Legenstein E; Müller M
Wien Klin Wochenschr; 1979 Mar; 91(6):201-4. PubMed ID: 85372
[TBL] [Abstract][Full Text] [Related]
18. Serum AFP and AFP-L3 in clinically distinguished hepatocellular carcinoma from patients with liver masses.
Subwongcharoen S; Leelawat K; Treepongkaruna SA; Narong S
J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S46-51. PubMed ID: 21717878
[TBL] [Abstract][Full Text] [Related]
19. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of alpha-fetoprotein assay in ascitic fluid for the diagnosis of hepatocellular carcinoma.
Miédougé M; Salama G; Barange K; Vincent C; Vinel JP; Serre G
Clin Chim Acta; 1999 Feb; 280(1-2):161-71. PubMed ID: 10090533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
